Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy

NCT01070758 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3

Enrollment

OTHER_GOV

Sponsor class

Conditions

Congenital Hyperinsulinism

Interventions

DRUG: Lanreotide autogel

Sponsor

Sheba Medical Center